Thorne Healthtech Inc Revenue Growth Rates (THRN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Thorne Healthtech Inc   (NASDAQ: THRN)
 

THRN's Revenue Growth by Quarter and Year

Thorne Healthtech Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

THRN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 72.71
1st Quarter March 65.24
FY 137.95





THRN Revenue second quarter 2023 Y/Y Growth Comment
Thorne Healthtech Inc achieved in the second quarter 2023, above Company average Revenue growth of 33.08% year on year, to $ 72.71 millions.

Looking into second quarter 2023 results within Major Pharmaceutical Preparations industry 87 other companies have achieved higher Revenue growth. While Thorne Healthtech Inc ' s Revenue rise of 33.08% ranks overall at the positon no. 668 in the second quarter 2023.


THRN Revenue ( Y/Y Growth %) 2023
 2022 2021 2020
4th Quarter December - 19.49 % 28.6 % -
3rd Quarter September - 21.68 % - -
2nd Quarter June 33.08 % 27.4 % - -
1st Quarter March 20.75 % 21.47 % - -
FY   - 22.37 % 377.79 % -

Financial Statements
Thorne Healthtech Inc 's second quarter 2023 Revenue $ 72.71 millions THRN's Income Statement
Thorne Healthtech Inc 's second quarter 2022 Revenue $ 54.64 millions Quarterly THRN's Income Statement


THRN Revenue (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
4th Quarter December - 1.99 % 3.85 % -
3rd Quarter September - 6.92 % 11.94 % -
2nd Quarter June 11.46 % 1.13 % -3.57 % -
1st Quarter March 9.5 % 8.36 % 14.73 % -
FY (Year on Year)   - 22.37 % 377.79 % -


Back to THRN Growth rate Comparisons >> Back to THRN Growth rate Comparisons >>


Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #88
Healthcare Sector #184
Overall #668

Revenue Y/Y Growth Statistics
High Average Low
29.69 % 23.57 % 19.33 %
(Jun 30 2023)   (Mar 31 2023)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #88
Healthcare Sector #184
Overall #668
Revenue Y/Y Growth Statistics
High Average Low
29.69 % 23.57 % 19.33 %
(Jun 30 2023)   (Mar 31 2023)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Thorne Healthtech Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
11.46 % 5.94 % 1.98 %
(Jun 30 2023)  


THRN's II. Quarter Q/Q Revenue Comment
Thorne Healthtech Inc achieved in the II. Quarter 2023 above company average sequential Revenue rise of 11.46%, to $ 72.71 millions, from $65.24 millions in the first quarter.
THRN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 110 other companies have achieved higher Revenue quarter on quarter growth. While Thorne Healthtech Inc 's Revenue growth quarter on quarter, overall rank is 1040.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #111
Healthcare Sector #240
Overall #1040
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #111
Healthcare Sector #240
Overall #1040
Revenue Q/Q Growth Statistics
High Average Low
11.46 % 5.94 % 1.98 %
(Jun 30 2023)  


THRN's II. Quarter Q/Q Revenue Comment
Thorne Healthtech Inc achieved in the II. Quarter 2023 above company average sequential Revenue rise of 11.46%, to $ 72.71 millions, from $65.24 millions in the first quarter.
THRN is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Major Pharmaceutical Preparations industry 110 other companies have achieved higher Revenue quarter on quarter growth. While Thorne Healthtech Inc 's Revenue growth quarter on quarter, overall rank is 1040.


Thorne Healthtech Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)		 12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 255.95 $ 237.87 $ 226.67 $ 216.95 $ 110.74
Y / Y Revenue Growth (TTM) 23.92 % 22.12 % 22.36 % 24.57 % -
Year on Year Revenue Growth Overall Ranking # 231 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 7.6 % 4.94 % 4.48 % 5.04 % -
Seq. Revenue Growth (TTM) Overall Ranking # 1668 # 1671 # 1746 # 569 # 0


Cumulative Revenue growth Comment
Although Thorne Healthtech Inc 's Annual Revenue growth year on year were below company's average 131.13% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.92% year on year, from 22.12% in Mar 31 2023.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 231.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 109
Healthcare Sector # 76
Overall # 231

Revenue TTM Y/Y Growth Statistics
High Average Low
131.13 %
 131.13 %
131.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 285
S&P 500 # 1668
Cumulative Revenue growth Comment
Although Thorne Healthtech Inc 's Annual Revenue growth year on year were below company's average 131.13% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.92% year on year, from 22.12% in Mar 31 2023.

In the Healthcare sector 75 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 231.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 109
Healthcare Sector # 76
Overall # 231

Revenue TTM Y/Y Growth Statistics
High Average Low
131.13 %
131.13 %
131.13 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 109
Sector # 285
S&P 500 # 1668




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
THRN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Ani Pharmaceuticals Inc57.81%$ 57.805 millions
Sera Prognostics Inc 57.69%$ 57.692 millions
Neuropace Inc 56.59%$ 56.588 millions
Xenetic Biosciences Inc 56.22%$ 56.225 millions
Blueprint Medicines Corporation55.70%$ 55.704 millions
Xencor Inc50.86%$ 50.863 millions
Xeris Biopharma Holdings Inc 50.19%$ 50.194 millions
Precipio inc 49.77%$ 49.767 millions
Dbv Technologies S a 49.64%$ 49.640 millions
Lensar Inc 49.44%$ 49.440 millions
Shockwave Medical Inc 48.80%$ 48.802 millions
Kyntra Bio Inc 48.69%$ 48.692 millions
Immunocore Holdings Plc48.62%$ 48.621 millions
4d Molecular Therapeutics Inc 47.53%$ 47.531 millions
Vycor Medical Inc 47.22%$ 47.220 millions
Aurinia Pharmaceuticals Inc 47.19%$ 47.189 millions
Standard Biotools Inc 47.00%$ 46.999 millions
Inovio Pharmaceuticals Inc 45.80%$ 45.805 millions
Halozyme Therapeutics Inc 45.07%$ 45.071 millions
Somalogic Inc 44.71%$ 44.712 millions
Castle Biosciences Inc 43.92%$ 43.918 millions
Lantheus Holdings Inc 43.79%$ 43.794 millions
Myomo Inc 43.60%$ 43.602 millions
Recursion Pharmaceuticals Inc 43.56%$ 43.563 millions
Harrow Inc 43.51%$ 43.506 millions
Kymera Therapeutics Inc 43.42%$ 43.417 millions
Zai Lab Limited42.94%$ 42.943 millions
Progyny Inc 42.89%$ 42.890 millions
Outset Medical Inc 42.49%$ 42.487 millions
Biotricity Inc 41.86%$ 41.859 millions


About Thorne Healthtech Inc Revenue Growth Rates (THRN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Thorne Healthtech Inc (CIK 1844280).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0000950170-23-040161
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Thorne Healthtech Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.